NET INCOME PER COMMON SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator [Abstract]
Net income	$ 3,544	$ 259	$ 272	$ 3,839	$ 2,426	$ 4,489	$ 4,076	$ 10,754
Less: preferred stock dividend	(304)			(304)			(912)	(912)
Less: allocation to preferred stockholders	(540)			(582)			(522)	(1,629)
Less: allocation to restricted stockholders	(155)			(232)			(153)	(634)
Net income allocated to common stockholders	$ 2,545			$ 2,721			$ 2,489	$ 7,579
Denominator [Abstract]
Weighted average common shares outstanding (in shares)	25,381,447			25,135,381			25,692,094	25,043,357
Basic income per share (in dollars per share)	$ 0.1			$ 0.11			$ 0.1	$ 0.3
Denominator [Abstract]
Weighted average number of common shares outstanding (in shares)	25,381,447			25,135,381			25,692,094	25,043,357
Diluted shares outstanding (in shares)	25,381,447			25,135,381			25,692,094	25,043,357
Diluted income per share (in dollars per share)	$ 0.1			$ 0.11			$ 0.1	$ 0.3
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of loss per share (in shares)	6,929,621			6,196,739			6,963,849	6,205,018
Series A Preferred Stock [Member]
Denominator [Abstract]
Dilutive potential common shares outstanding (in shares)	0			0			0	0
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of loss per share (in shares)	5,381,356			5,381,356			5,381,356	5,381,356
Unvested Restricted Stock [Member]
Denominator [Abstract]
Dilutive potential common shares outstanding (in shares)	0			0			0	0
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of loss per share (in shares)	1,548,265			815,383			1,582,493	823,662